Exelixis Acquires Agritope, Expanding its Agribusiness Reach | GenomeWeb

NEW YORK, Sept. 8 -- Seeking to extend the use of its model organism and comparative genomics technologies, Exelixis (Nasdaq: EXEL) said Thursday it had agreed to acquire agricultural genomics company Agritope (Nasdaq: AGTO) in an all stock deal valued at $68 million.

Exelixis of San Francisco will offer between 0.28 and 0.35 of a share for each of the Portland, Ore.-based company's 4.5 million outstanding shares. The offer, which puts a $14 pricetag on Agritope's shares, represents a 114 percent premium on Thursday's closing price of $6 17/32.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.